The Cureus Journal of Medical ScienceAngiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review and Meta-AnalysisType 2 diabetes mellitus (T2DM) increases the risk of cardiovascular morbidity and end-stage renal disease. Renin-angiotensin-aldosterone….1 day ago

The Cureus Journal of Medical ScienceAngiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review and Meta-AnalysisType 2 diabetes mellitus (T2DM) increases the risk of cardiovascular morbidity and end-stage renal disease. Renin-angiotensin-aldosterone….1 day ago

Related posts

FDA approves Lilly’s Onswik for type 2 diabetes in adults

ADHD and autism appear more common among young people diagnosed with type 2 diabetes

FDA approves once-weekly basal insulin Onswik for type 2 diabetes